{
    "case_number": "CAC-UDRP-108913",
    "time_of_filling": "2026-08-09 21:41:08",
    "domain_names": [
        "novartisplarmlab.com"
    ],
    "case_administrator": "Olga Slanařová (Case admin)",
    "complainant": [
        "Novartis AG  "
    ],
    "complainant_representative": "Abion GmbH",
    "respondent": [
        "PropertyManagement Services INC"
    ],
    "respondent_representative": null,
    "factual_background": "<p><span>The Complainant, Novartis AG, is a Swiss pharmaceutical company and the holding company of the Novartis Group.&nbsp;<\/span><\/p>\n<p><span>The Complainant owns, inter alia, the domain names &lt;novartis.com&gt; and &lt;novartispharma.com&gt;.<\/span><\/p>\n<p><span>The disputed domain name &lt;novartisplarmlab.com&gt; was registered on April 10, 2026.<\/span><\/p>\n<p><span>The evidence shows that the disputed domain name has resolved to a website presenting itself as \"Novartis Pharmaceuticals and Laboratories\" and promoting pharmaceutical products, anti-viral drugs, vaccines and pharmaceutical research. The website prominently uses the NOVARTIS name.<\/span><\/p>",
    "other_legal_proceedings": "<p>The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>",
    "no_response_filed": "<p>The Complainant contends that the requirements of the Policy have been met and that the disputed domain name should be transferred to it. <br \/>No administratively compliant Response has been filed.<\/p>",
    "rights": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>",
    "no_rights_or_legitimate_interests": "<p>The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>",
    "bad_faith": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>",
    "procedural_factors": "<p>The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>",
    "decision": "Accepted",
    "panelists": [
        "Karel Šindelka"
    ],
    "date_of_panel_decision": "2026-09-23 00:00:00",
    "informal_english_translation": "<p><span>The Complainant is the owner of numerous trademark registrations for NOVARTIS, including, inter alia:<\/span><\/p>\n<ul>\n<li><span> International Trademark NOVARTIS No. 663765, registered on July 1, 1996;<\/span><\/li>\n<li><span> European Union Trademark NOVARTIS No. 013393641, registered on March 17, 2015; and<\/span><\/li>\n<li><span> United States Trademark NOVARTIS No. 4986124, registered on June 28, 2016 <\/span>(\"NOVARTIS Trademarks\").&nbsp;<\/li>\n<\/ul>",
    "decision_domains": {
        "novartisplarmlab.com": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}